XML 40 R31.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

9 Months Ended

Sep. 30, 2011


	Three Months Ended						Nine Months Ended
	September 30, 2011			October 1, 2010			September 30, 2011			October 1, 2010
Sales:
Test & Measurement	$	856.7		$	697.2		$	2,535.4		$	2,031.5
Environmental		734.6			678.6			2,133.2			1,986.3
Life Sciences & Diagnostics		1,567.4			559.8			2,898.8			1,616.4
Dental		492.6			443.0			1,460.8			1,303.1
Industrial Technologies		866.8			714.2			2,547.3			2,065.2
Businesses contributed to Apex joint venture attributable to periods prior to contribution		—			—			—			315.6

	$	4,518.1		$	3,092.8		$	11,575.5		$	9,318.1


Operating Profit:
Test & Measurement	$	205.2		$	145.0		$	567.6		$	414.1
Environmental		158.5			143.4			445.8			398.0
Life Sciences & Diagnostics		52.1			69.1			177.0			138.3
Dental		71.5			57.3			176.0			140.1
Industrial Technologies		187.2			151.4			549.3			421.4
Businesses contributed to Apex joint venture:
Attributable to period prior to contribution		—			—			—			41.5
Equity method earnings subsequent to JV formation		16.0			10.6			44.9			10.6
Other		(34.4	)		(23.7	)		(87.8	)		(71.6	)

	$	656.1		$	553.1		$	1,872.8		$	1,492.4

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details